191 related articles for article (PubMed ID: 2579503)
1. Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.
Ooi A; Kameya T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
Virchows Arch A Pathol Anat Histopathol; 1985; 405(3):311-23. PubMed ID: 2579503
[TBL] [Abstract][Full Text] [Related]
2. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
3. MEN I pancreas: a histological and immunohistochemical study.
Thompson NW; Lloyd RV; Nishiyama RH; Vinik AI; Strodel WE; Allo MD; Eckhauser FE; Talpos G; Mervak T
World J Surg; 1984 Aug; 8(4):561-74. PubMed ID: 6207668
[No Abstract] [Full Text] [Related]
4. Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural, and biochemical study of 32 cases.
Capella C; Polak JM; Buffa R; Tapia FJ; Heitz P; Usellini L; Bloom SR; Solcia E
Cancer; 1983 Nov; 52(10):1860-74. PubMed ID: 6627205
[TBL] [Abstract][Full Text] [Related]
5. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
[TBL] [Abstract][Full Text] [Related]
7. PreproVIP-derived peptides in tissue and plasma from patients with VIP-producing tumours.
Rønnov-Jensen D; Gether U; Fahrenkrug J
Eur J Clin Invest; 1991 Apr; 21(2):154-60. PubMed ID: 1647952
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
[TBL] [Abstract][Full Text] [Related]
9. The morphology and neuroendocrine profile of pancreatic epithelial VIPomas and extrapancreatic, VIP-producing, neurogenic tumors.
Solcia E; Capella C; Riva C; Rindi G; Polak JM
Ann N Y Acad Sci; 1988; 527():508-17. PubMed ID: 2839087
[TBL] [Abstract][Full Text] [Related]
10. Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin.
Gutniak M; Rosenqvist U; Grimelius L; Lundberg JM; Hökfelt T; Rökaeus A; Rosell S; Lundqvist G; Fahrenkrug J; Sundblad R; Gutniak E
Acta Med Scand; 1980; 208(1-2):95-100. PubMed ID: 7001860
[TBL] [Abstract][Full Text] [Related]
11. Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene.
Bloom SR; Christofides ND; Delamarter J; Buell G; Kawashima E; Polak JM
Lancet; 1983 Nov; 2(8360):1163-5. PubMed ID: 6139527
[TBL] [Abstract][Full Text] [Related]
12. Multiple nonfunctional pancreatic islet cell tumor in multiple endocrine neoplasia type I. A case report.
Takahashi H; Nakano K; Adachi Y; Aoki N; Hajiro K; Yamamoto T; Higashizawa T; Chikugo T; Suzuki T
Acta Pathol Jpn; 1988 May; 38(5):667-82. PubMed ID: 2905567
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an alpha-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP).
Maltèse JY; Monge G; Giraud P; Salers P; Ouafik LH; Pelen F; Oliver C
Clin Endocrinol (Oxf); 1990 Oct; 33(4):467-80. PubMed ID: 2171816
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man.
Fahrenkrug J; Pedersen JH; Yamashita Y; Ottesen B; Hökfelt T; Lundberg JM
Regul Pept; 1987 Jul; 18(1):51-61. PubMed ID: 3306816
[TBL] [Abstract][Full Text] [Related]
15. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain.
Fahrenkrug J; Emson PC
J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin-producing insulinoma. An immunohistochemical and electron microscopic study.
Ooi A; Nakanishi I; Kameya T; Funaki Y; Kobayashi K
Acta Pathol Jpn; 1986 Dec; 36(12):1897-903. PubMed ID: 3030043
[TBL] [Abstract][Full Text] [Related]
18. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
19. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
Fahrenkrug J
Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions.
Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD
Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
